Having extinguished all debt and significantly reduced cost-base, RedHill is now focused on late-stage pipeline advancement, in collaboration with U.S. and...

Related Keywords

United States , United Kingdom , Johannesburg , Gauteng , South Africa , American , Adi Frish , Redhill Biopharma , Dror Ben Asher , Company Expanded Access Program , International Journal Of Infectious Diseases , Nuclear Medical Countermeasures Acute Radiation Syndrome , Company American Depositary Shares Adss , Us Army , Development Expenses , European Commission , National Institutes Of Health , University Of Tennessee , Trademark Office , Company Annual Report On Form , International Journal Of Nephrology , National Institute Of Allergy , Regulatory Agency , Redhill Biopharma Ltd , Drug Administration , Nuclear Countermeasures Program , Business Development , Nasdaq , Nasdaq Stock Market , Product Development Pipeline , Talicia Warranty Program , Movantik Acquisition Co , Exchange Commission , Company Adss , Redhill Biopharma Inc , Acute Radiation Syndrome , Animal Rule , Priority Review Voucher , Authorisation Application , Hill Biopharma , Chief Executive Officer , Administrative Expenses , Cash Used , Operating Activities , Cash Provided , Financing Activities , Operating Loss , Nasdaq Listing Rule , American Depositary Shares , Nasdaq Global Market , Healthcare Royalty , Obesity Week , World Gastro , Infectious Disease Product , Medical Countermeasures , Priority Review , National Institute , Infectious Diseases , National Institutes , United States Patent , International Journal , Renovascular Disease , Nontuberculous Mycobacteria , Orphan Drug Designation , Marketing Authorisation Application , United Kingdom Medicines , Private Securities Litigation Reform Act , Development Pipeline , Expanded Access Program , Annual Report , Ended December , Warranty Program ,